Close Menu

This article has been updated with additonal information from Courtagen Life Sciences and Medicinal Genomics.

NEW YORK (GenomeWeb) – Courtagen Life Sciences said today that it has closed its diagnostic neurology testing business. According to the firm's website, it no longer accepts patient samples. 

The company's wholly owned subsidiary, Medicinal Genomics Corporation (MGC), which provides cannabis genetics research and testing, will remain intact and Courtagen is taking on this name.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.